Roger Adsett
CIK 1685904 · Chief Operating Officer · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$9.65M
Companies
3
Total Filings
49
Lifetime Open-Market Net
-$30.70M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 3 of 5
49 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-01-11 | INSM | Sell (S) | −7,373 | -$214.4K | EDGAR |
| 2024-01-05 | INSM | Mixed | +9,831 | -$88.9K | EDGAR |
| 2023-06-15 | INSM | Sell (S) | −8,981 | -$173.5K | EDGAR |
| 2023-05-24 | Landos Biopharma, Inc. (LABP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-17 | INSM | Sell (S) | −6,816 | -$127.2K | EDGAR |
| 2023-05-15 | INSM | Grant (A) | +31,662 | $0 | EDGAR |
| 2023-01-12 | INSM | Sell (S) | −3,194 | -$57.5K | EDGAR |
| 2023-01-06 | INSM | Mixed | +4,554 | -$60.1K | EDGAR |
| 2022-11-22 | INSM | Sell (S) | −11,855 | -$222.9K | EDGAR |
| 2022-06-09 | Landos Biopharma, Inc. (LABP) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.